Search Results - "Trsová, Iva"

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1 by Trsova, Iva, Hrustincova, Andrea, Krejcik, Zdenek, Kundrat, David, Holoubek, Aleš, Staflova, Karolina, Janstova, Lucie, Vanikova, Sarka, Szikszai, Katarina, Klema, Jiri, Rysavy, Petr, Belickova, Monika, Kaisrlikova, Monika, Vesela, Jitka, Cermak, Jaroslav, Jonasova, Anna, Dostal, Jiri, Fric, Jan, Musil, Jan, Dostalova Merkerova, Michaela

“…Mutations in the splicing factor 3b subunit 1 (SF3B1) gene are frequent in myelodysplastic neoplasms (MDS). Because the splicing process is involved in the…”
Get full text

Risk Assessment in Patients with Myelodysplastic Neoplasms Using the Molecular International Prognostic Scoring System: A Single-Center Study from the Czech Republic by Vesela, Jitka, Votavova, Hana, Kaisrlikova, Monika, Lenertova, Zuzana, Kundrat, David, Trsová, Iva, Ransdorfova, Sarka, Mikulenkova, Dana, Cermak, Jaroslav, Belickova, Monika

Get full text

Accelerated Progression in Lower-Risk Myelodysplastic Neoplasms: Attenuated Cell Cycle, DNA Damage Response, and Augmented Oncogenic Transcriptome Signatures by Kaisrlikova, Monika, Lenertová, Zuzana, Koralkova, Pavla, Trsová, Iva, Kundrat, David, Dostalova Merkerova, Michaela, Votavova, Hana, Krejcik, Zdenek, Jonasova, Anna, Cermak, Jaroslav, Divoky, Vladimir, Belickova, Monika

“…Patients with myelodysplastic neoplasms (MDS) face the risk of transformation to acute myeloid leukemia (AML). Although prognostic scoring systems exist for…”
Get full text

Molecular Mechanisms Underlying Abnormal Activation of T Cells in Idiopathic Aplastic Anemia and Hypoplastic Myelodysplastic Neoplasms by Lenertová, Zuzana, Kaisrlikova, Monika, Kundrat, David, Votavova, Hana, Vesela, Jitka, Trsová, Iva, Ransdorfova, Sarka, Marinov, Iuri, Prochazka, Tomas, Lysak, Daniel, Jonasova, Anna, Čermák, Jaroslav, Belickova, Monika

“…Idiopathic aplastic anemia (AA) and hypoplastic myelodysplastic neoplasms (MDS-h) are severe hematopoietic disorders characterized by pancytopenia and…”
Get full text

Different Mutations in SF3B1 Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms by Trsová, Iva, Hrustincova, Andrea, Belickova, Monika, Kaisrlikova, Monika, Lenertová, Zuzana, Kundrat, David, Krejcik, Zdenek, Vesela, Jitka, Cermak, Jaroslav, Jonasova, Anna, Dostalova Merkerova, Michaela

“…Myelodysplastic neoplasms (MDS) are hematopoietic stem cell (HSC) disorders characterized by ineffective hematopoiesis, peripheral cytopenia, and increased…”
Get full text

Upregulation of ZEB1-Derived Circular RNAs Is Associated with SF3B1-Mutated Myelodysplastic Neoplasms by Trsová, Iva, Belickova, Monika, Hrustincova, Andrea, Kaisrlikova, Monika, Lenertova, Zuzana, Kundrat, David, Krejcik, Zdenek, Vesela, Jitka, Klema, Jiri, Ryšavý, Petr, Cermak, Jaroslav, Dostalova Merkerova, Michaela

Get full text

Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes by Kaisrlikova, Monika, Trsová, Iva, Lenertova, Zuzana, Vesela, Jitka, Kundrat, David, Votavova, Hana, Dostalova Merkerova, Michaela, Krejcik, Zdenek, Vostry, Martin, Cermak, Jaroslav, Belickova, Monika

Get full text

Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms by Kaisrlikova, Monika, Kundrat, David, Koralkova, Pavla, Trsova, Iva, Lenertova, Zuzana, Votavova, Hana, Merkerova, Michaela Dostalova, Krejcik, Zdenek, Vesela, Jitka, Vostry, Martin, Simeckova, Radka, Markova, Marketa Stastna, Lauermannova, Marie, Jonasova, Anna, Cermak, Jaroslav, Divoky, Vladimir, Belickova, Monika

“…Patients with myelodysplastic neoplasms (MDS) are classified according to the risk of acute myeloid leukemia transformation. Some lower‐risk MDS patients…”
Get full text

Circular RNAs in Myelodysplastic Syndromes and Impact of SF3B1 Mutations on Their Expression by Dostalova Merkerova, Michaela, Kundrat, David, Krejcik, Zdenek, Hrustincova, Andrea, Trsova, Iva, Szikszai, Katarina, Kaisrlikova, Monika, Vesela, Jitka, Klema, Jiri, Cermak, Jaroslav, Belickova, Monika

“…Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases with a high risk of transformation to acute myeloid leukemia (AML). One of the processes…”
Get full text

Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes by Merkerova, Michaela Dostalova, Klema, Jiri, Kundrat, David, Szikszai, Katarina, Krejcik, Zdenek, Hrustincova, Andrea, Trsova, Iva, LE, Anh Vu, Cermak, Jaroslav, Jonasova, Anna, Belickova, Monika

“…Prediction of response to azacitidine (AZA) treatment is an important challenge in hematooncology. In addition to protein coding genes (PCGs), AZA efficiency…”
Get full text